All posts in category Biologics

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

DermatologistsBlog.com Interview with Prof Dr. Ana GImenez-ArnauDepartment of Dermatology.Hospital del Mar. IMIM. Universitat Autònoma Barcelona DermatologistsBlog.com: What are the main findings of the study? Dr. Gimenez-Arnau: The main issue of this study was to demonstrate the efficacy of omalizumab obtaining relief of the urticaria symptoms (itch and hives) of moderate to severe chronic spontaneous urticaria in patients who are [...]

by on March 26, 2013  •  Permalink
Posted in Author Interviews, Biologics, Hives - Urticaria, Medications
Posted by admin on March 26, 2013

http://dermatologistsblog.com/medications/biologics-2/omalizumab-for-the-treatment-of-chronic-idiopathic-or-spontaneous-urticaria/

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis   DermatologistsBlog.com Authors’ Interview: Joan Paul, MD, MPH,Virginia Clinical Research Inc, 601 Medical Tower, Norfolk, VA 23507. Robert J. Pariser, MD, Department of Dermatology, Eastern Virginia Medical School, Norfolk, VirginiaVirginia Clinical Research Inc, Norfolk, Virginia DermatologistsBlog.com: What are the main findings of the [...]

by on January 3, 2013  •  Permalink
Posted in Author Interviews, Biologics
Posted by admin on January 3, 2013

http://dermatologistsblog.com/medications/biologics-2/a-double-blind-randomized-placebo-controlled-trial-of-adalimumab-in-the-treatment-of-cutaneous-sarcoidosis/

Psoriasis with Palmo-Plantar Involvement : Methotrexate vs. Acitretin

Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study DermatologistsBlog Author Interview: Dr A J Kanwar  MD, FAMS, FRCP (London) Prof and Head, Dept of Dermatology, Venereology & Leprology PGIMER, Chandigarh DermatologistsBlog: What are the main findings of the study? Methotrexate at a dose of [...]

by on November 2, 2012  •  Permalink
Posted in Author Interviews, Biologics, Medications, Methotrexate, Psoriasis, Pustular
Tagged , ,
Posted by admin on November 2, 2012

http://dermatologistsblog.com/psoriasis/psoriasis-with-palmo-plantar-involvement-methotrexate-vs-acitretin/

Risk of Skin Cancer with anti TNF therapy in RA

Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies Author Interview: Dr Pierre Le Blay CCA_AHU CHU Lapeyronie, Montpellier FRANCE DermatologistsBlog.com:  What are the main findings of the study? We were interested in risk of malignancy with [...]

by on September 8, 2012  •  Permalink
Posted in Author Interviews, Biologics, Medications, Psoriasis, Skin Cancer
Tagged , , , ,
Posted by admin on September 8, 2012

http://dermatologistsblog.com/psoriasis/risk-of-skin-cancer-with-anti-tnf-therapy-in-ra/

Safety of ustekinumab (Stelara) in patients with moderate-to-severe psoriasis and latent tuberculosis infection

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection Author Interview: Dr. Tsai, Tsen-Fang Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan DermatologistsBlog.com What are the main findings of the study? This study evaluated the safety of isoniazid (INH) prophylaxis for newly identified latent tuberculosis infection (LTBI) in patients [...]

by on July 20, 2012  •  Permalink
Posted in Author Interviews, Biologics, Biologics, Psoriasis, Ustekinumab - Stelara
Posted by admin on July 20, 2012

http://dermatologistsblog.com/psoriasis/safety-of-ustekinumab-stelara-in-patients-with-moderate-to-severe-psoriasis-and-latent-tuberculosis-infection/

Psoriatic Arthritis: Authors’ Interview Drs. Day & Goodman

Psoriatic Arthritis Authors’  Interview: Michael Sean Day, MD, MPhil and Susan Goodman, MD From the Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, NY (Dr. Day), and the Department of Rheumatology (Dr. Goodman), Hospital for Special Surgery, New York. What are the main findings of the review? DMARDs (disease-modifying antirheumatic drugs) and biologics are the mainstay [...]

1 Comment
by on January 28, 2012  •  Permalink
Posted in Author Interviews, Biologics, Psoriasis, Psoriatic Arthritis
Tagged , ,
Posted by admin on January 28, 2012

http://dermatologistsblog.com/psoriasis/psoriatic-arthritis-authors-interview-drs-day-goodman/

Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: Dr. Wolf

Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial. Author Interview Peter Wolf, MD Professor of Dermatology  & Bioimmunotherapy Department of Dermatology Medical University of Graz Auenbruggerplatz 8 A-8036 Graz, Austria What are the main findings of the study? 311-nm narrowband UVB phototherapy significantly accelerated psoriatic lesion clearance in [...]

No Comments
by on January 12, 2012  •  Permalink
Posted in Author Interviews, Biologics, Ustekinumab - Stelara, UV Light, UV Therapy
Tagged , ,
Posted by admin on January 12, 2012

http://dermatologistsblog.com/uv-light/treatment-with-311-nm-ultraviolet-b-enhanced-response-of-psoriatic-lesions-in-ustekinumab-treated-patients-dr-wolf/

Squamous Cell Carcinomas in Psoriasis treated with Etanercept : Author Interview Dr. Brewer

Author Interview: Jerry D. Brewer, MD Department of Dermatology Mayo Clinic 200 First St SW Rochester MN 55095 US Multiple squamous cell carcinomas in the setting of psoriasis treated with etanercept: a report of four cases and review of the literature What are the main findings of the study? This study was a small case [...]

No Comments
by on December 21, 2011  •  Permalink
Posted in Author Interviews, Biologics, Etanercept - Enbrel, Psoriasis, Squamous Cell Cancer
Tagged , , ,
Posted by admin on December 21, 2011

http://dermatologistsblog.com/psoriasis/squamous-cell-carcinomas-in-psoriasis-treated-with-etanercept-author-interview-dr-brewer/

Rheumatoid Arthritis Biologic Drugs May Increase Risk of Skin Cancer

Malignancies associated with tumor necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta analysis Biological agents used to treat rheumatoid arthritis seem to be associated with an increased risk of skin cancer, indicates a systematic review of published research in the Annals of the Rheumatic Diseases. Inflammatory arthritis has been [...]

1 Comment
by on September 8, 2011  •  Permalink
Posted in Biologics, Skin Cancer
Tagged , ,
Posted by admin on September 8, 2011

http://dermatologistsblog.com/skin-cancer/rheumatoid-arthritis-biologic-drugs-may-increase-risk-of-skin-cancer/

Etanercept (Enbrel) helped some dermatomyositis patients wean off steroids

A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy. These results are encouraging, but larger studies are needed to further investigate the safety and efficacy of etanercept. Results of this clinical trial are available in Annals [...]

No Comments
by on June 17, 2011  •  Permalink
Posted in Biologics, Dermatomyositis, Etanercept - Enbrel
Tagged ,
Posted by admin on June 17, 2011

http://dermatologistsblog.com/connective-tissue-disease/dermatomyositis/etanercept-enbrel-helped-some-dermatomyositis-patients-wean-off-steroids/

  • Categories

  • Twitter

  • Psoriasis Walk at Philly ZooPsoriasis Walk at Philly ZooPsoriasis Walk at Philly Zoo

  • National Eczema Association

    National Eczema Association

    National Eczema Association

  • Pages

  • Dermatology Research Studies from NIH

    Search the NIH Data Base Dermatology Research Studies

  • Dermatology Meetings & Skin Care Events

    May  2013
    MTWTFSS
     12345
    6789101112
    13141516171819
    20212223242526
    2728293031 

  • Categories

    AAD 2012 Dermatology Interviews AAD American Academy Dermatology Acne Actinic Keratosis Aging Skin Allergies Alopecia - Atopic Dermatitis - Eczema Author Interviews Basal Cell Carcinoma Bedbugs Biologics Botulinum Toxin - Botox BRAF Connective Tissue Disease Contact Dermatitis Cosmeceuticals Cosmetics Cosmetic Surgery Eczema FDA Announcements Genetic Research Head Lice Herpes Zoster/Shingles HPV Infections Itch Lyme Medications Melanoma MRSA National Psoriasis Foundation Pediatric Dermatology Psoriasis Psoriatic Arthritis Skin Cancer Squamous Cell Cancer Stem Cells Sunburns Sunscreens Tanning Booths UV Light Vitamin D Vitiligo Warts_Papilloma Virus